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Summary 
Asthma and chronic obstructive pulmonary disease (COPD) are chronic lung diseases; 
COPD mainly affects older people, while asthma affects people of all ages. Asthma death 
rates in Australia are high compared with many other countries and COPD is a leading cause 
of death in Australia (AIHW 2014) and internationally (Lozano et al. 2012). Many deaths due 
to these conditions are potentially preventable.  
This report presents current information about mortality due to asthma and COPD in 
Australia, examining trends over time, seasonal variation, international comparisons and 
variation by age, sex, remoteness, Indigenous status, country of birth and socioeconomic 
disadvantage. To reduce overlap with asthma, COPD mortality data in this report refer only 
to people aged 55 and over. 
Asthma  
Since 1911, the mortality rate due to asthma in Australia has fluctuated, with several peaks 
observed in the late 1950s, mid-1960s and late 1980s. In recent years, the mortality rate due to 
asthma has declined substantially, but remains relatively high on an international scale. 
In Australia in 2011, asthma was certified as the underlying cause of 378 deaths (1.5 per 
100,000 people) which represented 0.3% of all deaths in Australia. This included 17 deaths 
among people aged 5–34 (0.2 per 100,000 people in this age group). The median age at death 
due to asthma was 80 in 2007–2011. 
Deaths due to asthma:  
• occur in all age groups but increase with age in both males and females 
• are higher in females compared to males aged 35 and over, but similar in males and 
females aged 5–34  
• peak in late winter for those aged 64 and over.  
Chronic obstructive pulmonary disease (COPD) 
In Australia in 2011, COPD was certified as the underlying cause of 5,767 deaths among 
people aged 55 and over (102 per 100,000 people aged 55+), representing 4.4% of all deaths in 
that age group in that year. The median age of death due to COPD was 81 in 2007–2011.  
Death rates due to COPD: 
• approximately halved between 1979 and 2011 among males 
• increased between 1979 and 1997 among females and then declined 
• increase with age and are almost double in males compared to females 
• are lowest in late summer and usually highest in the late winter months. 
Deaths due to asthma and COPD are higher among 
• people from English-speaking compared to non-English-speaking countries of birth 
• people residing in Remote areas of Australia compared to Major cities 
• Indigenous Australians compared to non-Indigenous Australians 
• people residing in areas of greatest socioeconomic disadvantage. 
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1 Introduction 
The purpose of this report is to provide up-to-date information about mortality due to 
asthma and chronic obstructive pulmonary disease (COPD) in Australia and to place this in a 
long-term context (see Box 1.1). The report includes data on number of deaths and years of 
life lost due to premature death, and examines trends over time and variation by age, sex, 
remoteness of residence, Indigenous status, country of birth and socioeconomic status. 
Seasonal variation and international comparisons are also presented. The report focuses on 
analyses up to 2011, the most recent year for which data were available for detailed analysis. 
Box 1.1: What are asthma and COPD? 
Asthma is a chronic lung disease, which can be controlled but not cured. In clinical practice, 
asthma is defined by the presence of both of the following: (1) excessive variation in lung 
function (that is, variation in expiratory airflow that is greater than that seen in healthy 
people) and (2) respiratory symptoms (for example, wheeze, shortness of breath, cough, 
chest tightness) that vary over time and may be present or absent at any point in time 
(National Asthma Council Australia 2014).  
COPD is usually acquired after a long period of exposure to inhaled noxious agents, such as 
cigarette smoke, and is characterised by airflow limitation that is not fully reversible and by 
associated exertional breathlessness. It mainly affects older people, and is usually 
progressive over time. COPD may be associated with emphysema and/or chronic bronchitis. 
The terms COPD, emphysema and chronic bronchitis tend to be used interchangeably in 
everyday language.  
In older people, there are often difficulties in the attribution of causes of death due to some 
respiratory conditions, particularly asthma and COPD (Jones et al. 1999; Sears et al. 1986; 
Smyth et al. 1996). This is because of the complexity of doctor diagnosis of respiratory 
problems in the elderly, and the considerable overlap between diagnoses of asthma, chronic 
bronchitis and emphysema (Abramson 2005; Marks et al. 2009).  
COPD mainly affects older people, while asthma affects people of all ages. For this reason, 
and to reduce overlap with asthma due to diagnostic complexities, COPD mortality data in 
this report refer only to people aged 55 and over.  
The report focuses primarily on deaths where asthma or COPD was listed as the underlying 
cause of death, that is, the condition which is ‘deemed to have started the train of events that 
led to death’ (ABS 2003). Asthma was certified as the underlying cause of 378 deaths in 2011. 
This corresponds to an asthma mortality rate of 1.5 per 100,000 population and represents 
0.3% of all deaths in that year. COPD was certified as the underlying cause of 5,767 deaths 
among people aged 55 and over in 2011. This corresponds to a COPD mortality rate of 102 
per 100,000 population aged 55 and over and represents 4.4% of all deaths among this age 
group in that year. 
Most deaths due to asthma and COPD occur in older people, many of whom have other 
diseases. Therefore, this report also explores asthma and COPD as associated causes of death in 
people whose deaths are due to other underlying causes (see Box 1.2).  
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Box 1.2: Terminology for deaths due to or associated with asthma and COPD and 
mortality rates 
The underlying cause of death is the disease or injury that initiated the train of events leading 
directly to death, or the circumstances of the accident or violence that produced the fatal 
injury.  
In this report, in the context of discussion about cause of death, the phrase ‘due to’ is used 
to refer to the condition recorded on the death certificate as the underlying cause of death.  
Associated causes of death are all causes listed on the death certificate, other than the 
underlying cause of death. They include the immediate cause, any intervening causes, and 
conditions which contributed to the death but were not related to the disease or condition 
causing the death (ABS 2013).  
In this report, the word ‘involving’ is used to refer to conditions that are recorded on the 
death certificate as the underlying or associated causes of death. 
A mortality rate due to a specific condition is the number of deaths due to that condition 
divided by the population during a specified time period. Rates are generally multiplied by 
a number such as 100,000 to create whole numbers. In this report, all the mortality rates 
presented are age-standardised (see ‘age-standardisation’ in Glossary). 
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2 Time trends in deaths due to asthma 
and COPD 
Asthma 
All ages 
In Australia, deaths due to asthma decreased in the first half of the 20th century before three 
peaks in asthma mortality occurred in the 1950s, 1960s and late 1980s respectively. Since 
then, deaths have declined substantially (Figure 2.1).  
Little is known about the reasons for major fluctuations in asthma mortality rates in the first 
half of the 20th century. Some of the variation may be attributable to changes in the 
International Classification of Diseases (despite the use of comparability factors to attempt to 
adjust for these changes, see Appendix) or to other changes in diagnostic or labelling 
practices.  
The peaks in asthma mortality observed in the 1960s and 1980s were probably attributable to 
the overuse of high potency reliever medications that became available at those times 
(Abramson et al. 2001; Campbell et al. 1992). See Asthma in Australia 2011 for more 
information (ACAM 2011).  
After the 1980s peak, the death rate declined by almost 70% to 1.6 per 100,000 population in 
2003 and has remained stable, below 2.0 per 100,000 population, since then. In 2011, the 
mortality rate due to asthma was 1.5 per 100,000 population.  
Similar long-term time trends in asthma deaths were observed in England and Wales 
between 1901 and 2004 (Anderson et al. 2007; Marks & Burney 1997). An increase in all-age 
deaths due to asthma occurred at the beginning of the 1960s, peaking in the mid-1960s, and 
was then followed by a decrease. During the late 1970s and early 1980s mortality rates 
gradually increased again, but have since declined. 
People aged 5–34  
Attribution of death to asthma is more certain among people aged 5–34 (Campbell et al. 1992; 
Malmstrom et al. 2007); thus this age group is commonly used for examining time trends and 
for making international comparisons.  
For people aged 5–34, long term fluctuations in the rate of death due to asthma are similar to 
those for the whole population (Figure 2.1). There has been little change in the rate of 
mortality due to asthma in this age group over the last 6–7 years. In 2011, there were 17 
deaths due to asthma in this age group in Australia, corresponding to a mortality rate of 0.2 
per 100,000 population aged 5–34 years.  
Among people aged 5–34, the asthma mortality rate was higher among females than males 
between the 1930s and late-1960s. However, in contrast to the trend observed in the 
population as a whole, there has been little difference between the sexes in the rate of 
mortality due to asthma in this age range since then (Figure 2.1). 
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Notes 
1. Age-standardised to the Australian population as at 30 June 2001.  
2. The vertical lines indicate years in which there were changes to the International Classification of Diseases (ICD).  
3. Asthma classified according to International Classification of Diseases. Deaths coded to ICD-2 (1911-1922), ICD-3 (1923–1929), ICD-4 
(1930–1939), ICD-5 (1940–1949), ICD-6 (1950–1957), ICD-7 (1958–1967), ICD-8 (1968–1978) and ICD-9 (1979–1996) were converted to 
ICD-10 (1997 onwards; codes J45 and J46) using conversion factors. See Appendix for source and methodology details including conversion 
factors. 
Sources: AIHW National Mortality Database; AIHW GRIM Books. 
Figure 2.1: Long-term death rates due to asthma, 5-year moving average, by sex, all ages and people 
aged 5–34 years, 1911–2011 
The reason for the recent reduction in the rate of asthma mortality is uncertain. There has 
been no corresponding decline in the prevalence of asthma among adults (ACAM 2011). 
Hence, the reduction in deaths due to asthma is likely to be due to a decreased risk of dying 
from asthma. Factors that may have contributed to this favourable outcome include: 
• the introduction of asthma management guidelines in 1989 (Woolcock et al. 1989) 
• changes in the availability and use of inhaled corticosteroid treatment for asthma 
• policy initiatives at state and national levels, including targeted funding and increased 
awareness among health professionals and patients with asthma, over this period [for 
example, the Asthma Cycle of Care (formerly the Asthma 3+ Visit Plan) (Department of 
Health and Ageing 2010)]  
• better diagnosis of asthma and COPD, followed by more accurate cause-of-death 
certification. 
Further interpretation of long-term mortality trends is provided in Asthma in Australia 2011 
(ACAM 2011). 
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COPD  
People aged 55 and over 
COPD is a serious long-term lung disease that mainly affects older people, while asthma 
affects people of all ages. For this reason, and to reduce overlap with asthma, COPD 
mortality data in this report refer only to people aged 55 and over.  
Death rates due to COPD in Australia increased among males in the late 1960s then 
decreased substantially between 1970 and 2011, from 422 to 139 per 100,000 population 
(Figure 2.2). Among females, death rates due to COPD increased from 35 per 100,000 in 1964 
to 108 per 100,000 population in 1996 but have since declined, although rates in 2011 were 
still higher than those observed in 1964 (86 per 100,000 population). 
Tobacco smoking is the predominant cause of COPD (Fletcher & Peto 1977). In Australia, 
smoking rates among males have historically been higher than those observed among 
females. In the mid-1940s, the majority of males (72%) in Australia were smokers, compared 
to only 26% of females. However, smoking rates among males have steadily declined in 
Australia since 1945. In contrast, smoking rates among females increased until the 1970s and 
then began to decline. 
It remains difficult to interpret the relationship between smoking rates and COPD because of 
the known long lag time between smoking uptake and death due to COPD. However, the 
decline in COPD mortality in men since the late 1960s and in women since the mid-1990s 
probably reflect declines in smoking prevalence that started at least 20 or 30 years earlier. 
In contrast to asthma, where pharmacological treatment almost certainly reduced case 
fatality rates, there is no evidence of a similar benefit for people with COPD. Hence, changes 
in the use of medications for COPD are unlikely to have influenced the time trends in 
mortality due to this disease.  
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Notes 
1. Age-standardised to the Australian population as at 30 June 2001.  
2. Vertical lines indicate changes to the International Classification of Diseases (ICD) which occurred in 1967, 1978 and 1997. 
3. COPD classified according to ICD-7 codes 501, 502, 526, 527.1, ICD-8 codes 518, 490, 491, 492, 519.8, ICD-9 codes 490, 491, 492, 494, 
496 and ICD-10 codes J40–J44, J47.  
4. Smoking data for the first 5 data points (1945, 1964, 1969, 1974 and 1976) were from public opinion polls (for example, Gallup polls). They 
included people describing themselves as 'current smokers', smoking any combination of cigarettes, pipes or cigars. Age ranges for 1945, 
1964 and 1969 were not specified, but presumed to be aged 21 years and over. Data for 1974 and 1976 were for people aged 16 and 
over.The subsequent points (1980 onwards) were from the National Surveys undertaken by the Cancer Council Victoria of people aged 15 
years and over. Prior to 2001, figures represent those describing themselves as 'current smokers' (no frequency specified). Since 2001 the 
figures include those reporting that they smoked 'daily' or 'at least weekly', and include people smoking any combination of cigarettes, pipes 
or cigars. 
5. See Appendix for further source and methodology details. 
Sources: AIHW National Mortality Database, Cancer Council Victoria. 
Figure 2.2: Death rates due to COPD among people aged 55 years and over, 3-year moving average, 
1964–2011 and smoking rates, 1945–2011, by sex 
 
Data from England show a similar pattern in deaths due to COPD. Mortality rates for COPD 
decreased among males aged 55 and over between 1979 and 2007; however, unlike asthma 
deaths, COPD mortality among females aged 55 and over in England increased slightly over 
the same period (Goldacre et al. 2012). 
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Comparison with trends in all-cause deaths  
Asthma deaths as a proportion of all-cause deaths 
Asthma deaths represent a larger proportion of deaths due to all causes (referred to here as 
‘all-cause deaths’) among people aged 5 to 34 than among all ages. 
Among people of all ages, the proportion of all-cause deaths due to asthma peaked in the 
late 1980s. This confirms that the peak in the rate of asthma deaths observed at that time 
(Figure 2.3) was over and above any change in the total number of deaths in Australia over 
the same period. This pattern was observed among both males and females.  
A marked peak in the proportion of all-cause deaths due to asthma was observed among 
people aged 5–34 over the same period, particularly among females, for whom the 
proportion of asthma deaths peaked at 3.7% in 1987.  
Since the peak in the late 1980s there has been a decline in the proportion of all deaths due to 
asthma, which has been observed in both males and females. This indicates that the observed 
improvements in asthma mortality are additional to the overall increase in longevity during 
this time.  
 
Note: Asthma classified according to International Classification of Diseases. Deaths coded to ICD-7 (1958–1967), ICD-8 (1968–1978) and ICD-9 
(1979–1996) were converted to ICD-10 (1997 onwards; codes J45 and J46) using conversion factors. See Appendix for source and methodology 
details including conversion factors. 
Source: AIHW GRIM books. 
Figure 2.3: Asthma deaths as a proportion of all-cause deaths by sex, people aged 5–34 years and all 
ages, 3-year moving average, 1964–2011 
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COPD deaths as a proportion of all-cause deaths among people 
aged 55 and over 
The proportion of all-cause deaths due to COPD among those aged 55 and over has 
stabilised in recent years (Figure 2.4). Among females, the proportion of all deaths due to 
COPD increased steadily from 1964 to 1996 and has remained relatively constant since 1997. 
In contrast, among males the proportion of all deaths due to COPD peaked in 1989 after 
which time there was a decline in the proportion of all deaths due to COPD until 2006, after 
which the proportion has been relatively constant. 
 
Note: COPD classified according to ICD-7 codes 501, 502, 526, 527.1, ICD-8 codes 518, 490, 491, 492, 519.8, ICD-9 codes 490, 491, 492, 494, 
496 and ICD-10 codes J40–J44, J47. 
Source: AIHW National Mortality Database. 
Figure 2.4: COPD deaths as a proportion of all-cause deaths by sex, people aged 55 years and over,  
3-year moving average, 1964–2011 
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International comparisons 
Asthma 
Mortality rates due to asthma in Australia are relatively high in comparison with many other 
countries. Although similar rates are reported for the United States and the United Kingdom 
(Figure 2.5), other countries such as Poland, Italy, Japan, Germany, and France have lower 
rates of mortality due to asthma than Australia. (See also the section on Country of birth in 
this report.) 
 
 
Notes  
1. Data are for countries reporting to the World Health Organization Statistical Information System (WHOSIS) Mortality Database in International 
Classification of Diseases, 10th Revision (ICD-10) format (J45 and J46). Analysis of these data was undertaken by the Australian Centre for 
Airways disease Monitoring (ACAM) and all interpretations and conclusions published here are those of ACAM and not WHO, which is 
responsible only for the provision of the original data.  
2. Data for Australia were sourced separately (see below).  
3. For each country, data are the average over one or more years during the period 2007–2011 (years of coverage for each country are shown 
in brackets). The horizontal bar on each point estimate represents the 95% confidence interval (i.e. the true estimate for each country has a 
95% probability of being between the left and right limit of this horizontal line). 
4. Rates are age-standardised to the WHO World Standard Population (Ahmad et al. 2001).  
5. Data are included only for those countries for which age-standardised data were available for the period 2007–2011 and for which the relative 
standard error for the average asthma mortality rate was less than 25%.  
Sources: Data were obtained from the WHO Mortality Database for all countries, except Australia. Data for Australia for 2007–2011 were obtained 
from the AIHW National Mortality Database. 
Figure 2.5: World ranking of asthma mortality rates, people aged 5–34 years, 2007–2011  
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A study involving 20 developed countries reported an overall pattern of higher asthma 
mortality rates in the late 1960s and mid-1980s among people aged 5–34 (Wijesinghe et al. 
2009). After the late 1980s, there was a reduction in asthma mortality rates in many of these 
countries and, in 2005, the rates of asthma mortality were similar in Australia, the United 
States, and England and Wales. Lower rates were reported in Germany, the Netherlands and 
Spain.  
It is important to note that there are insufficient data to determine the likely causes of the 
variations in asthma mortality among countries. The global mortality rates due to asthma do 
not appear to correlate with the prevalence of the condition (GINA 2012). 
COPD 
COPD was the 3rd leading cause of death worldwide in 2010 (Lozano et al. 2012). 
The rate of mortality due to COPD in Australia is lower than in several other developed 
countries, including the United States, New Zealand and the United Kingdom (Figure 2.6). 
However, the Australian rates are higher than those reported for Japan, France, Sweden and 
Finland. (See also the section on Country of birth in this report.) 
In the United States, the COPD mortality rate among adults aged 25 years and over was 
reported at 63.1 per 100,000 population in 2010 (Ford et al. 2013). In the Asia-Pacific region 
between 1991 and 2004, reported mortality rates due to COPD among people aged 40 and 
over ranged from 30.0 per 100,000 population in South Korea to 73.0 per 100,000 population 
in Hong Kong. In this same period, the reported rate for Australia (56.0 per 100,000 
population) was within this range (Tan et al. 2009).  
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Notes  
1. Data are for countries reporting to the World Health Organization Statistical Information System (WHOSIS) Mortality Database in 
International Classification of Diseases, 10th Revision (ICD-10) format (J40–J44). Analysis of these data was undertaken by the Australian 
Centre for Airways disease Monitoring (ACAM) and all interpretations and conclusions published here are those of ACAM and not WHO, 
which is responsible only for the provision of the original data.  
2. Data for Australia were sourced separately (see below).  
3. For each country, data are the average over one or more years during the period 2007–2011 (years of coverage for each country are shown 
in brackets). The horizontal bar on each point estimate represents the 95% confidence interval (i.e. the true estimate for each country has a 
95% probability of being between the left and right limit of this horizontal line). 
4. Rates are age-standardised to the WHO World Standard Population (Ahmad et al. 2001). Only those countries for which the relative 
standard error for the average COPD mortality rate was less than 25% are included.  
Sources: Data were obtained from the WHO Mortality Database for all countries, except Australia. Data for Australia for 2007–2011 were obtained 
from the AIHW National Mortality Database. 
Figure 2.6: World ranking of COPD mortality rates, people aged 55 years and over, 2007–2011  
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3 Years of life lost 
The burden of mortality due to asthma and COPD can be expressed as the years of life lost 
(YLL) due to these diseases. This represents the life expectancy at the time of death, summed 
over all deaths due to these diseases. The result can be expressed as years of life lost per 
100,000 population. YLLs take into account both the number of deaths and the age at which 
they occur by giving greater weight to deaths at a younger age and lower weight to deaths at 
an older age (WHO 2011). Therefore, YLL is more sensitive than mortality counts or rates to 
the effects of interventions that prevent premature deaths.  
Between 1964 and the mid-1980s, YLL due to asthma declined before a large peak in the late 
1980s (Figure 3.1). The decline and peak over this time was evident among males and 
females and mirrored the pattern seen in long term trends in the age-standardised rate of 
asthma deaths (Figure 2.1).  
YLL due to COPD declined among males between the 1970s and 2005 and has since 
remained steady (Figure 3.2). In contrast, among females, YLL due to COPD steadily rose 
from 1964 to the late 1990s. Since this time, the YLL due to COPD among females has 
declined, but is still much higher than the rate observed in the 1960s and 1970s. This may be 
related to the different pattern of smoking uptake between males and females whereby the 
prevalence of smoking increased in women up to the mid-1970s but has been decreasing in 
men since the 1940s (Adair et al. 2012).  
 
Source: AIHW National Mortality Database. 
Figure 3.1: Years of life lost (YLL) due to asthma, 3-year moving average rate, 1964–2011 
0
20
40
60
80
100
120
140
19
64
19
65
19
66
19
67
19
68
19
69
19
70
19
71
19
72
19
73
19
74
19
75
19
76
19
77
19
78
19
79
19
80
19
81
19
82
19
83
19
84
19
85
19
86
19
87
19
88
19
89
19
90
19
91
19
92
19
93
19
94
19
95
19
96
19
97
19
98
19
99
20
00
20
01
20
02
20
03
20
04
20
05
20
06
20
07
20
08
20
09
20
10
20
11
Year of death 
YLL due to asthma, per 100,000 population 
Males
Females
  Mortality from asthma and COPD in Australia 13 
 
Source: AIHW National Mortality Database. 
Figure 3.2: Years of life lost (YLL) due to COPD, 3-year moving average rate, 1964–2011  
 
For deaths due to asthma, mortality rates and YLL from 1964 to 2011 have shown 
remarkably similar trends (Figure 3.3). This indicates that, over this period, there has been no 
change in the age distribution of deaths due to asthma except what is attributable to overall 
increase in life expectancy over this period.  
In contrast, YLL due to COPD declined less than mortality rates due to COPD between 1980 
and 2000, which indicates that, relative to the increase in life expectancy over this period, the 
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words, prevention of premature death due to other causes, such as heart disease, was more 
effective than prevention of premature death due to COPD during the last two decades of 
the 20th century. 
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Note: ASR=age standardised mortality rate. 
Source: AIHW National Mortality Database. 
Figure 3.3: Years of life lost (YLL) and mortality rate due to asthma and COPD as a proportion of 
total YLL, 3 year moving average, 1964–2011 
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4 Population subgroups 
Age and sex 
Asthma 
While deaths due to asthma occur in all age groups, the risk of dying from asthma increases 
with age in both males and females (Figure 4.1). The median age at death due to asthma was 
80 years between 2007 and 2011. COPD deaths are also most common in older people 
(median age at death 81 years from 2007–2011). There is substantial overlap in the clinical 
features of asthma and COPD. As a result, the attribution of death to one or the other of these 
diseases in older people is not reliable in clinical practice or in mortality statistics. [See 
Asthma in Australia 2011 for more information (ACAM 2011).] 
Death rates due to asthma among children aged 0–4 and 5–14 were less than or equal to 0.2 
per 100,000 population during the period 2007–2011, while rates in people aged 15–34 and 
35–64 were 0.4 and 1.1 per 100,000 population, respectively (Figure 4.1). 
Among people aged 5–34, the rate of mortality due to asthma is higher among males than 
females. However, among people aged 35 and over the rate of death due to asthma is higher 
in females than males (Figure 4.1). This could be due to several reasons, for example, asthma 
is much more prevalent in women than in men and there is evidence of diagnostic bias by 
 
Notes: 
1. Age-specific mortality rates calculated for aggregated data from 2007–2011.  
2. Age-standardised to the Australian population as at June 2001. 
3. Asthma classified according to International Classification of Diseases, 10th Revision (ICD-10) codes J45 and J46. 
Source: AIHW National Mortality Database. 
Figure 4.1: Death rates due to asthma, by age and sex, 2007–2011  
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gender, with GPs more likely to assign the diagnosis of COPD to male rather than female 
patients (Han et al. 2007).  
COPD 
Between 2007 and 2011, the median age of death from COPD was 81 years. Among people 
aged 55 and over, the risk of dying from COPD increased with age (Figure 4.2) and was 1.8 
times higher in males (136 per 100,000 population) than in females (76.0 per 100,000 
population). The disparity between males and females also increased with age. Among 
people aged 55–64, the mortality rate due to COPD among males was 1.2 times that of 
females, while among people aged 85 and over, the mortality rate among males was 2.2 
times that of females. 
This may reflect a higher prevalence of smoking or smoking history among males in this 
cohort. Rates of smoking have steadily declined in males in Australia since the mid-1940s 
(see Figure 2.2). 
 
Notes 
1. Age-specific mortality rates calculated for aggregated data from 2007–2011.  
2. Age-standardised to the Australian population as at June 2001.  
3. COPD classified according to International Classification of Diseases, 10th Revision (ICD-10) codes J40–J44. 
Source: AIHW National Mortality Database. 
Figure 4.2: Death rates due to COPD, by age and sex, people aged 55 years and over, 2007–2011  
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Remoteness 
Asthma 
Mortality rates due to asthma increased with increasing remoteness of residence. Mortality 
rates due to asthma were higher among people residing in Outer regional and Remote/Very 
remote areas than in Major cities and Inner Regional areas (Figure 4.3). This pattern applied 
across all age groups. This finding is consistent with the observation that a high proportion 
of deaths due to asthma that were reported to the coroner were for people living in rural or 
remote areas (45%) despite only 32% of the overall Australian population residing in these 
areas (Goeman et al. 2013).  
This pattern is consistent with the regional variation observed for hospital separations for 
asthma (ACAM 2011) and all-cause hospital separations (AIHW 2013) among adults. These 
results may reflect regional variation in access to health care. 
 
  
 
 
Notes  
1.  Age-standardised to the Australian population as at June 2001. Mortality rates for aggregated data from 2009–2011.  
2. Asthma classified according to International Classification of Diseases, 10th Revision (ICD-10) codes J45 and J46.  
3.  Remoteness classified according to the Australian Statistical Geographical Standard (ASGS) categories of remoteness (ABS 2011).  
4. Due to diagnostic complexities and, hence, difficulties in attribution of asthma deaths in children aged 0–4 years, only asthma deaths among 
those aged 5 years and over are reported here. 
Source: AIHW National Mortality Database. 
Figure 4.3: Death rates due to asthma, by remoteness, people aged 5 years and over, 2009–2011 
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COPD 
Among people aged 55 and over, mortality rates due to COPD increased with remoteness of 
residence (Figure 4.4). The highest death rate due to COPD occurred in Remote/Very remote 
areas. This pattern was seen in all age groups. 
 
Notes  
1. Age-standardised to the Australian population as at June 2001. Mortality rates for aggregated data from 2009–2011.  
2. COPD classified according to International Classification of Diseases, 10th Revision (ICD-10) codes J40–J44.  
3. Remoteness classified according to the Australian Statistical Geographical Standard (ASGS) categories of remoteness (ABS 2011).  
Source: AIHW National Mortality Database. 
Figure 4.4: Death rates due to COPD, by remoteness, people aged 55 years and over, 2009–2011 
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Aboriginal and Torres Strait Islander people 
Aboriginal and Torres Strait Islander people (referred to in this report as Indigenous 
Australians) experience higher overall mortality rates than non-Indigenous Australians (ABS 
2012). Furthermore, the Indigenous Australian population (median age 21.8 in 2011) has a 
younger age structure than the non-Indigenous population (median age 37.6 in 2011) (ABS 
2013). 
During the period from 2007 to 2011, the mortality rate for asthma among Indigenous 
Australians of all ages was 4.0 per 100,000 population, which was 2.3 times that of non-
Indigenous Australians (1.7 per 100,000 population; Figure 4.5). The mortality rate due to 
asthma increased with age among Indigenous Australians and non-Indigenous Australians 
(Figure 4.5) and the disparity in the mortality rate between Indigenous Australians and non-
Indigenous Australians was greatest among those aged 35–54 years. 
 
Notes  
1. Asthma classified according to International Classification of Diseases, 10th Revision (ICD-10) codes J45 and J46.  
2. The analysis was limited to data from New South Wales, Queensland, Northern Territory, Western Australia and South Australia because 
these are the only jurisdictions where the recording of Indigenous status on death certificates is considered adequate for reporting statistics 
on Indigenous mortality. 
Source: AIHW National Mortality Database. 
Figure 4.5: Death rates due to asthma, by broad age group and Indigenous status, 2007–2011 
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During the period from 2007 to 2011, the mortality rate for COPD among Indigenous 
Australians aged 55 and over was 263 per 100,000 population, 2.6 times that of non-
Indigenous Australians (101 per 100,000 population; Figure 4.6). The disparity in the 
mortality rate for COPD between Indigenous and non-Indigenous Australians was greatest 
among those aged 55–59 years. In this age group, the mortality rate for COPD among 
Indigenous Australians was 7 times that of non-Indigenous Australians. Deaths due to 
COPD among Indigenous Australians and non-Indigenous Australians aged 55 and over 
increased with age (Figure 4.6). 
 
 
Notes  
1. COPD classified according to International Classification of Diseases, 10th Revision (ICD-10) codes J40–J44. 
2. The analysis was limited to data from New South Wales, Queensland, Northern Territory, Western Australia and South Australia because 
these are the only jurisdictions where the recording of Indigenous status on death certificates is considered adequate for reporting statistics 
on Indigenous mortality. 
Source: AIHW National Mortality Database. 
Figure 4.6: Death rates due to COPD, by broad age group and Indigenous status, 2007–2011 
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Country of birth 
Asthma 
Among people aged 5 and over, the mortality rate due to asthma was higher among people 
born in Australia or in other English-speaking countries (2.0 per 100,000 population) 
compared with those from a non-English-speaking country of birth (1.3 per 100,000 
population). The disparity was largest among those aged 5–34 years. In this age group, 
people from an English-speaking country of birth were 4 times as likely to die from asthma 
as those from a non-English-speaking country of birth (Figure 4.7).  
The mortality rate due to asthma was similar among people born in Australia and people 
born in other English-speaking nations who subsequently migrated to Australia (Figure 4.7). 
 
ESCoB=English-speaking country of birth 
NESCoB=non-English-speaking country of birth 
Notes  
1. Age-standardised to the Australian population as at June 2001.  
2. Mortality data aggregated from 2007–2011.  
3. Asthma classified according to International Classification of Diseases, 10th Revision (ICD-10) codes J45 and J46.  
4. English-speaking country of birth includes anyone born in Australia, New Zealand, Canada, United Kingdom, Ireland, United States of 
America, South Africa or Zimbabwe. Non-English-speaking country of birth includes all those born in other countries.  
5.  Due to diagnostic complexities and, hence, difficulties in attribution of asthma deaths in children aged 0–4 years, only asthma deaths among 
those aged 5 years and over are reported here. 
Source: AIHW National Mortality Database. 
Figure 4.7: Death rates due to asthma, by country of birth, people aged 5 years and over, 2007–2011  
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COPD 
Among people aged 55 and over, the mortality rate due to COPD was twice as high among 
people born in Australia or in other English-speaking countries (115 and 124 per 100,000 
population, respectively) compared with those from a non-English-speaking country of birth 
(56.5 per 100,000 population). The disparity was largest among people aged 55 to 64, where 
the mortality rate for those born in Australia was 3.8 times the rate for those from a non-
English-speaking country of birth (Figure 4.8). There was no difference in the mortality rate 
due to COPD between people born in Australia and people born in other English-speaking 
countries who subsequently migrated to Australia. 
  
Notes  
1. Age-standardised to the Australian population as at June 2001.  
2. Mortality data aggregated from 2007–2011.  
3. COPD classified according to International Classification of Diseases, 10th Revision (ICD-10) codes J40– J44.  
4. English-speaking country of birth includes anyone born in New Zealand, Canada, United Kingdom, Ireland, United States of America, South 
Africa or Zimbabwe. Non-English-speaking country of birth includes all those born in other countries. 
Source: AIHW National Mortality Database. 
Figure 4.8: Death rates due to COPD, by country of birth, people aged 55 years and over, 2007–2011  
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Areas of socioeconomic disadvantage 
Asthma 
Socioeconomic factors may influence asthma control and health-seeking behaviours. In 
children, various studies have shown that severe asthma is associated with lower 
socioeconomic status and poverty (Babin et al. 2007; Mielck et al. 1996). Studies from 
Australia and the United States of America also show a higher risk of asthma mortality 
related to lower socioeconomic status (Castro et al. 2001; Goeman et al. 2013; Grant et al. 
2000). This is reflected in data from the AIHW National Mortality Database, which show 
higher asthma mortality rates among those residing in areas of lowest socioeconomic status 
(2.4 per 100,000 population) compared to those residing in areas of highest socioeconomic 
status (1.3 per 100,000 population; Figure 4.9).  
  
SES = Socioeconomic status 
Notes 
1. Age-standardised to the Australian population as at June 2001.  
2.  Mortality data aggregated from 2009–2011.  
3.  Asthma classified according to International Classification of Diseases, 10th Revision (ICD-10) codes J45 and J46. 
4. Due to diagnostic complexities and, hence, difficulties in attribution of asthma deaths in children aged 0–4 years, only asthma deaths among 
those aged 5 years and over are reported here. 
Source: AIHW National Mortality Database. 
Figure 4.9: Death rates due to asthma, by socioeconomic status, people aged 5 years and over,  
2009–2011  
The disparity is particularly evident among people aged 5–34 in whom asthma mortality 
rates are four times as high among those living in areas of lowest socioeconomic status (0.4 
per 100,000 population) compared with those residing in areas of highest socioeconomic 
status (0.1 per 100,000 population; data not shown).  
It should be noted that for the data presented here, socioeconomic status is based on the area 
of usual residence and, hence, reflects the relative disadvantage of all people living in an 
area, not necessarily that of an individual. 
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COPD 
Mortality due to COPD among people aged 55 and over is almost double among those 
residing in areas of lowest socioeconomic status (123 per 100,000 population) compared with 
those residing in areas of highest socioeconomic status (65.2 per 100,000 population; Figure 
4.10). 
SES = Socioeconomic status 
Notes 
1.  Age-standardised to the Australian population as at June 2001.  
2.  Mortality data aggregated from 2009–2011.  
3.  COPD classified according to International Classification of Diseases, 10th Revision (ICD-10) codes J40–J44. 
Source: AIHW National Mortality Database. 
Figure 4.10: Death rates due to COPD, by age and socioeconomic status, people aged 55 years and 
over, 2009–2011  
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5 Seasonal variation in mortality risk 
There are more deaths due to all causes in the colder months and fewer deaths in the warmer 
months in Australia (AIHW: De Looper 2002). The winter peak is more pronounced in 
infants and older Australians. In younger people, a peak in overall deaths is seen in warmer 
months, reflecting the seasonality of the major causes of death in these age groups including 
motor vehicle accidents, suicide and drowning (AIHW: De Looper 2002).  
Similarly, the risk of death due to asthma and COPD varies with the time of year and is 
different between age groups (Figures 5.1 and 5.2).  
Asthma 
Deaths due to respiratory conditions overall are higher between May and September, which 
corresponds to the winter months in the southern part of Australia (AIHW: De Looper 2002).  
Recent data for Australia in the period 2007–2011 (Figure 5.1) show no seasonal differences 
in asthma deaths among people aged 5–34 and 35–64, contrasting with the peak in warmer 
months for all-cause mortality in these two age groups.  
 
Notes  
1.  Asthma classified according to International Classification of Diseases, 10th Revision (ICD-10) codes J45 and J46.  
2.  Mortality data aggregated from 2007–2011. For each month, the average age-standardised rate over the 5-year period was calculated for the 
relevant age group.  
3. Due to diagnostic complexities and, hence, difficulties in attribution of asthma deaths in children aged 0–4 years, only asthma deaths among 
those aged 5 years and over are reported here. 
Source: AIHW National Mortality Database. 
Figure 5.1: Seasonal variation in the rate of deaths due to asthma, by broad age group, 2007–2011  
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In contrast with younger age groups, there was higher mortality due to asthma in people 
aged 85 and over in late winter (August) over the period 2007–2011. This pattern could 
reflect the impact of winter rises in influenza and pneumonia, which contribute to acute 
exacerbations leading to increased risk of hospitalisations and death. A similar peak is seen 
in winter months for older patients in other countries. Studies from the United States of 
America (Weiss 1990) and the United Kingdom (Fleming et al. 2000; Marks & Burney 1997) 
demonstrated higher rates of asthma deaths during winter months among older people.  
COPD 
Australian data show that COPD deaths tend to be highest in the late winter months (July 
and August), with the peak most pronounced among those aged 85 years and over (Figure 
5.2). The lowest rates of mortality due to COPD are observed around February. 
 
 
Notes  
1. COPD classified according to International Classification of Diseases, 10th Revision (ICD-10) codes J40– J44.  
2. Mortality data aggregated from 2007–2011. For each month, the average age-standardised rate over the 5-year period was calculated for the 
relevant age group.  
Source: AIHW National Mortality Database. 
Figure 5.2: Seasonal variation in the rate of deaths due to COPD, people aged 55 years and over, 
2007–2011  
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6 Deaths involving asthma and COPD 
Death statistics are often based only on the underlying cause of death—that is, the disease or 
injury that initiated the train of events leading directly to death (See Box 1.2). Analysis of 
associated causes of death—either for deaths due to asthma or COPD, or for deaths due to 
other causes where asthma and/or COPD were involved in the death—may offer insights 
into the disease processes occurring at the end of life and give a more complete picture of all 
diseases involved in a death. 
Associated causes of death are all causes listed on the death certificate other than the 
underlying cause of death. They include the immediate cause, any intervening causes, and 
conditions that contributed to the death but were not related to the disease or condition 
causing the death (See Box 1.2).  
This section starts by describing the prevalence of selected associated causes of death listed 
on the death certificate where the underlying cause of death was asthma or COPD. The age 
range of this analysis is limited to those aged 55 and over since multiple associated causes of 
death are primarily relevant to older people. The associated causes of death we have 
presented were chosen on the basis of being in the top 20 leading causes of death among 
people aged 55 years and over between 2007 and 2011 [which were classified using an 
AIHW-modified version of Becker et al. (2006)] and potentially related to asthma or COPD 
due to either: 
• shared risk factors; 
• a potential causal relationship; or 
• causing complications in the management of asthma or COPD. 
Asthma 
Among people aged 55 and over whose underlying cause of death was listed as asthma, the 
most common associated causes of death were Influenza and pneumonia and COPD, which 
were listed on 35% and 33% of all death certificates, respectively (Table 6.1). Coronary heart 
diseases was listed as an associated cause of death in 19% of all asthma deaths. Heart failure 
and complications and ill-defined heart diseases was listed as an associated cause of death in 18% 
of all asthma deaths and Hypertensive diseases in 15% of all asthma deaths. 
Similar associated causes of death among people whose deaths were listed as due to asthma 
have been reported elsewhere. In France, where asthma was the underlying cause of death, 
cardiovascular disease was the most common associated cause of death among all ages (45%) 
and COPD was an associated cause of death in 11% of asthma deaths among those aged 65 
and over (Fuhrman et al. 2009). In England, the most common other certified causes in 
asthma deaths were pneumonia (36%), chronic ischemic heart disease (11%) and COPD (9%) 
(Goldacre et al. 2012).  
In recent years, there has been increasing interest in patients who have diagnoses or clinical 
features of both asthma and COPD (called the asthma-COPD overlap syndrome, or ACOS). 
This may include patients with long-standing asthma who have developed irreversible 
airflow limitation. Criteria for ACOS have varied, but the reported prevalence has ranged 
between 15–55% of patients with chronic airways disease (GINA 2014). Such patients have 
worse health outcomes, more exacerbations, and higher health utilisation than patients with 
either asthma or COPD alone (Andersen et al. 2013; Hardin et al. 2011). Australian data show 
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that approximately one-third of people whose deaths were listed as being due to asthma had 
COPD listed as an associated cause of death on their death certificate (Table 6.1), and hence 
could potentially have had ACOS. 
COPD 
Among people aged 55 and over whose underlying cause of death was COPD, the most 
common associated cause of death was Influenza and pneumonia, which was listed on 32.2% of 
all death certificates (Table 6.1). Coronary heart diseases was the next most common associated 
cause at 19.9% of COPD deaths and Heart failure and complications and ill-defined heart diseases 
was listed in 18.4% of cases. 
Table 6.1: Associated causes of death in people who died from asthma and COPD, age 55 years and 
over, 2007–2011 
 Proportion of deaths (per cent) 
Selected associated causes of death 
Asthma was underlying 
cause (n=1,647) 
COPD was underlying 
cause (n=26,766) 
Asthma 0.06* 0.44 
COPD 32.91 3.58* 
Coronary heart diseases 19.37 19.92 
Stroke 6.31 5.07 
Lung cancer 0.67 2.25 
Dementia and Alzheimer disease 11.72 7.93 
Diabetes mellitus 10.75 7.16 
Heart failure and complications and ill-defined heart diseases 17.91 18.44 
Influenza and pneumonia 34.97 32.21 
Hypertensive diseases 15.24 9.93 
* These two seemingly anomalous instances most probably reflect the range of disease codes used to define asthma and COPD, whereby the 
coding of underlying cause of death and associated cause of death appear to be the same but represent different individual ICD-10 codes used to 
define asthma and COPD in this report (see Tables A1 and A2). For example, a death may have had the underlying cause of death recorded as 
J46 Status asthmaticus and have J45.0 Predominantly allergic asthma listed as an associated cause of death, or vice versa. In the case of COPD, 
J43.2 Centrilobular emphysema and J44.9 COPD, unspecified may have been listed as the underlying cause and associated cause of death, or 
vice versa. 
Notes  
1. Contributing factors are not mutually exclusive. Therefore, the columns for each condition can add up to more than 100%. 
2. Asthma and COPD were classified according to International Classification of Diseases, 10th Revision (ICD-10) codes-—Asthma codes J45 
and J46, COPD codes J40–J44. Associated causes of death were also classified according to ICD-10 using the following codes: coronary 
heart diseases–codes I20–I25, stroke–codes I60–I69, lung cancer–codes C33–C34, dementia and Alzheimer disease–F00–F03 and G30, 
diabetes mellitus–E10–E14, heart failure and complications and ill-defined heart diseases–codes I50–I51, influenza and pneumonia–codes 
J09–J18, hypertensive diseases–codes I10–I15.  
Source: AIHW National Mortality Database. 
Asthma and COPD as associated causes of deaths due to other causes 
Reporting deaths based on the underlying cause of death only (as is commonly done) may 
underestimate the mortality contribution of other chronic diseases. This is particularly the 
case for highly prevalent, slowly progressive, chronic diseases such as asthma and COPD, as 
well as several other diseases, including end-stage renal failure, diabetes and dementia and 
Alzheimer disease (see AIHW 2012). 
In the period 2007–2011, of all deaths among those aged 55 and over with asthma as any 
cause of death (that is, recorded on the death certificate), only 27% had asthma recorded as 
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the underlying cause of death. Of all deaths with COPD as any cause, only 40% had COPD 
recorded as the underlying cause of death. 
Among deaths where Hypertensive diseases and Diabetes were the underlying causes of death, 
asthma was listed as an associated cause of death in 1.5% and 1.1% of cases, respectively. 
COPD was listed as an associated cause of death in 16.5% of deaths from Lung cancer and 
10.0% of deaths from Heart failure and complications and ill-defined heart diseases. 
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Appendix: Technical notes 
Registration of deaths is the responsibility of individual state and territory Registrars of 
Births, Deaths and Marriages. Information on the cause of death is provided to the Registrar 
by a medical practitioner certifying a death, or by the Coroner to whom a death is reported. 
This information is, in turn, supplied to the Australian Bureau of Statistics (ABS) for coding 
of cause of death, and compilation into aggregated statistics.  
The AIHW National Mortality Database comprises the coded cause of death data sourced 
from the ABS. As the registration of deaths is a legal requirement in Australia, this dataset is 
considered nearly complete, although there is no formal validation of completeness. The ABS 
advises that Aboriginal and Torres Strait Islander Australians are probably under-
enumerated in some of the states and territories. 
This report focuses primarily on analysis of the underlying cause of death reported on each 
certificate. However, Chapter 6 presents information on associated causes of death, which 
are other conditions listed on the death certificate that are not underlying cause of death.  
Deaths from 1997 onward were coded according to the International Statistical Classification 
of Disease and Related Health Problems 10th revision (ICD-10). Data before 1997 were 
classified using earlier versions of the International Classification of Diseases and, therefore, 
these data are not directly comparable with more recent data. To analyse long-term trends, 
where applicable, age-specific comparability factors were applied to data on deaths that 
occurred before 1997 (see ‘Comparability factors for mortality data’ section in this 
Appendix). 
There is some variation in the time frames presented for analyses throughout this report. For 
example, SEIFA and remoteness category breakdowns have been analysed over the period 
2009–2011 while other population subgroup analyses were for the period 2007–2011. This 
reflects differences in the availability of population data by SEIFA category and remoteness 
categories. 
Limitations in mortality data 
There are a number of issues affecting the reliability and validity of certification of deaths. 
The reliability of death certification can be influenced by variation in the propensity of 
attending medical practitioners to diagnose asthma or COPD and to label patients as dying 
from these conditions.  
Australian and international validation studies of asthma deaths coded on death certificates 
reveal that adult deaths from asthma can be under-counted (Guite & Burney 1996; Hunt et al. 
1993; Smyth et al. 1996) or over-counted (Jones et al. 1999; Sears et al. 1986; Sidenius et al. 
2000), depending on the awareness of asthma in a particular country. It is generally 
considered that asthma diagnosis is fairly unambiguous in people aged less than 45 years 
and data are, therefore, more reliable for these ages. However, under-enumeration of deaths 
due to asthma has also been demonstrated among children and young adults (Jorgensen et 
al. 2000).  
Generally, for older people the attribution of death to asthma, or alternatively to one of a 
range of illnesses with clinical features that overlap with asthma, is problematic, and 
therefore deaths data for asthma are less reliable for older people (Jones et al. 1999; Sidenius 
et al. 2000; Smyth et al. 1996).  
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Changes in classification schemes and/or coding have a quantifiable impact on time trends 
in deaths data. However, the extent to which changes over time in diagnostic practices affect 
deaths data is less well studied. We also know that asthma and COPD are more frequently 
coded as an associated cause of death rather than as an underlying cause of death, and this 
may underestimate their overall contribution to mortality in analyses that use underlying 
cause of death data only. 
Reliability of death certificates for deaths due to COPD was examined as part of a large 
clinical trial in which cause of death was adjudicated (Drummond et al. 2010). In 80% of 
cases, the primary or secondary cause of death from death certificates agreed with the 
adjudicated cause of death, but COPD was not listed on the death certificate in 21% of deaths 
adjudicated to be caused by COPD exacerbation.  
It should be noted that the data used in this report are not directly abstracted from the death 
certificate. ICD codes for underlying cause of death have been assigned according to coding 
standards designed to select the most likely underlying cause of death from those listed on 
the death certificate according to agreed rules. Various issues arise with coding deaths and 
these must be taken into account when interpreting deaths ‘due to’ a particular condition, 
including asthma and COPD. 
The data quality statements underpinning the AIHW National Mortality Database can be 
found in the following ABS publications:  
ABS Quality declaration summary for Causes of death 2012 (Cat. no. 3303.0) 
<http://www.abs.gov.au/Ausstats/abs@.nsf/0/D4A300EE1E04AA43CA2576E800156A24?
OpenDocument> and  
ABS Quality declaration summary for Deaths, Australia 2012 (Cat.no. 3302.0) 
<http://www.abs.gov.au/AUSSTATS/abs@.nsf/Lookup/3302.0Explanatory%20Notes1201
2?OpenDocument>. 
Cause of death codes 
The classification of asthma or COPD as the underlying cause of death was based on the 
ICD-2 (1911 to 1922), ICD-3 (1923 to 1929), ICD-4 (1930 to 1939), ICD-5 (1940 to 1949), ICD-6 
(1950 to 1957), ICD-7 (1958 to 1967), ICD-8 (1968 to 1978), ICD-9 (1979 to 1996) and ICD-10 
for deaths from 1997 onwards (see Tables A1 and A2 for ICD-10 codes and description).  
Data for asthma deaths were available from 1907 from the National Mortality Database. Data 
coded using ICD-1 (1907–1910) were not included in our analysis because emphysema and 
asthma were grouped together under code 119 and, therefore, we could not differentiate 
deaths attributed to asthma or emphysema (one form of COPD). 
Data for COPD deaths were available from 1964. 
Comparability factors (where applicable) were applied to data classified under ICD-2 
through to ICD-9 to make the data comparable to that coded using ICD-10 (see 
‘Comparability factors for mortality data’ section in this Appendix).  
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Table A1: ICD codes included for asthma mortality data from ICD versions ICD-2 to ICD-10 
ICD classification ICD-2 ICD-3 ICD-4 ICD -5 ICD-6 ICD7 ICD8 ICD 9 ICD-10 
Years covered 1911–22 1923–29 1930–39 1940–49 1950–57 1958–67 1968–78 1979–96 1997+ 
Description          
Asthma 96 105 112  241 241 493   
Status asthmaticus         J46 
Asthma, unspecified        493.9 J45.9 
Asthma with ‘flu as 
contributing or 
secondary cause’ 
   112.1      
Asthma without any 
of above 
complications 
   112.6      
Extrinsic asthma        493.0  
Intrinsic asthma        493.1  
Predominantly 
allergic asthma 
        J45.0 
Non-allergic asthma         J45.1 
Mixed asthma         J45.8 
Source: (WHO 2007). 
Table A2: ICD codes included for COPD mortality data from ICD versions ICD-7 to ICD-10 
ICD classification ICD-7 ICD-8 ICD-9 ICD-10 
Years covered (1958–67) (1968–78) (1979–96) (1997+) 
Description     
Bronchiectasis 526 518 494 J47 
Bronchitis, chronic and unqualified 501, 502 491 491  
Bronchitis, not specified as acute or chronic  490 490 J40 
Simple and mucopurulent chronic bronchitis   491.0, 491.1 J41 
Obstructive chronic bronchitis   491.2  
Unspecified chronic bronchitis   491.9 J42 
Emphysema  492 492 J43 
Emphysema without mention of bronchitis 527.1    
Other obstructive airways disease  519.8 496  
Other COPD    J44 
Source: (WHO 2007). 
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Comparability factors for mortality data 
Table A3 shows the age-group specific comparability factors calculated for converting 
number of asthma deaths from ICD-2, ICD-3, ICD-4, ICD-5, ICD-6, ICD-7, ICD-8, and ICD-9 
directly to ICD-10. For example, if there were 350 deaths due to asthma among males aged 
75 years and over using ICD-4, then you would multiply 350 by 0.88 (Table A3) to convert it 
to a comparable number of deaths coded to ICD-10. Thus 350 deaths among males aged 75 
and over using ICD-4 equates to 308 deaths coded to ICD-10.  
The method for calculating these comparability factors was described previously (ACAM 
2003, section A1.3). 
Table A3: Comparability factors for converting asthma mortality data coded using earlier ICD 
versions to ICD-10 
 
ICD 2 ICD 3 ICD 4 ICD 5 ICD 6 ICD7 ICD8 ICD 9 
Sex/Age group (1911-
1922) 
(1923-
1929) 
(1930–
1939) 
(1940-
1949) 
(1950–
1957) 
(1958–
1967) 
(1968–
1978) 
(1979–
1996) 
Males         
0–4 years 1.41 1.41 1.41 1.41 1.27 1.27 1.30 1.00 
5–14 years 1.41 1.41 1.41 1.41 1.27 1.27 1.30 1.00 
15–24 years 1.09 1.09 1.09 1.09 0.92 1.01 1.06 1.00 
25–34 years 0.96 0.94 0.91 0.88 0.82 1.00 1.06 1.00 
35–44 years 1.33 1.22 1.12 1.03 0.74 0.84 0.89 0.84 
45–54 years 1.24 1.13 1.04 0.95 0.65 1.01 1.12 0.84 
55–64 years 1.23 1.16 1.09 1.03 0.65 0.97 1.12 0.84 
65–74 years 0.99 0.93 0.88 0.83 0.49 0.79 0.91 0.68 
75 years and 
over 
0.99 0.93 0.88 0.83 0.49 0.79 0.91 0.68 
Females         
0–4 years 1.12 1.12 1.12 1.12 1.12 1.30 1.30 1.00 
5–14 years 1.12 1.12 1.12 1.12 1.12 1.30 1.30 1.00 
15–24 years 1.14 1.10 1.06 1.02 0.99 1.03 1.06 1.00 
25–34 years 1.17 1.13 1.08 1.04 0.85 1.01 1.06 1.00 
35–44 years 0.97 0.91 0.86 0.81 0.70 0.86 0.89 0.84 
45–54 years 1.62 1.46 1.31 1.18 0.91 1.08 1.12 0.84 
55–64 years 1.84 1.64 1.47 1.31 0.81 1.08 1.12 0.84 
65–74 years 1.30 1.12 0.97 0.84 0.54 0.87 0.91 0.68 
75 years and 
over 
1.30 1.12 0.97 0.84 0.54 0.87 0.91 0.68 
 
For the purposes of examining long-term trends in COPD mortality in this report, the codes 
used to define COPD were those outlined in Table A4. 
A published report on deaths attributed to COPD between 1901 and 1991 in Britain (Marks & 
Burney 1997) determined that there was less than 6% net change in deaths attributed to the 
condition after the introduction of ICD-6, ICD-7, ICD-8 and ICD-9 when COPD was defined 
using the codes in Table A2. 
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Analysis of Australian data from 1997 and 1998 that was coded using both ICD-9 and ICD-10 
codes (as defined in Table A2) demonstrated that there was less than 5% difference in deaths 
attributed to COPD after the introduction of ICD-10. This was true for all age groups and for 
males and females. Therefore, we concluded that conversion factors were not required for 
the purposes of analysing long-term trends in COPD data from as early as 1958 when COPD 
was defined using the codes outlined in Table A2. 
Calculation of years of life lost (YLL) 
To calculate YLL, conversion factors were first applied to the number of asthma deaths (see 
Table A3). There were no conversion factors applied to deaths due to COPD; see previous 
section ‘Comparability factors for mortality data’ for a detailed description. For asthma 
deaths, data for all ages were included in the calculation. For COPD deaths, only those aged 
55 years and over were included. The number of deaths were aggregated by sex, age and 
year. YLL were calculated from the aggregated number of deaths multiplied by a standard 
life expectancy at the age at which death occurs. The standard life expectancy used for YLL 
at each age was derived from ABS Life Tables. Missing data for life expectancy were 
estimated using linear interpolation. A rate per 100,000 population was calculated. 
Definitions of associated causes of death 
To examine associated causes of death among people whose underlying cause of death was 
asthma (ICD-10 codes J45, J46) or COPD (J40–J44), we examined the top 20 leading causes of 
death among people aged 55 years and over between 2007 and 2011 and selected diseases (or 
disease groups) potentially related to asthma and/or COPD due to either: 
• shared risk factors; 
• a potential causal relationship; or 
• causing complications in the management of asthma/COPD. 
These conditions were: 
• coronary heart diseases (I20–I25) 
• stroke (I60–I69) 
• lung cancer (C33–C34) 
• dementia and Alzheimer disease (F00–F03 and G30) 
• diabetes mellitus (E10–E14) 
• heart failure and complications and ill-defined heart diseases (I50–I51) 
• influenza and pneumonia (J09–J18) 
• hypertensive diseases (I10–I15). 
In the section investigating asthma as an associated cause of death when other conditions 
were listed as the underlying cause of death, the analyses undertaken for this report were 
confined to the same eight underlying causes of death listed above.  
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Glossary 
Aboriginal or Torres Strait Islander: A person of Aboriginal and/or Torres Strait Islander 
descent who identifies as an Aboriginal and/or Torres Strait Islander. See also Indigenous. 
Age-specific rate: A rate for a specific age group. The numerator and denominator relate to 
the same age group.  
Age-standardisation: A method of removing the influence of age when comparing 
populations with different age structures. This is usually necessary because the rates of many 
diseases vary strongly (usually increasing) with age. The age structures of the different 
populations are converted to the same ‘standard’ structure, then the disease rates that would 
have occurred with that structure are calculated and compared.  
ASGS classification: The Australian Statistical Geography Standard (ASGS) is a 
geographical classification which defines the level of accessibility to goods and services (such 
as general practitioners, hospitals and specialist care) based on the proximity to these 
services (measured by road distance) (ABS 2011). 
Associated causes of death: All causes listed on the death certificate, other than the 
underlying cause of death. They include the immediate cause, any intervening causes, and 
conditions which contributed to the death but were not related to the disease or condition 
causing the death. (See Box 1.2 for more information.) 
Asthma: Asthma is a chronic lung disease, which can be controlled but not cured. In clinical 
practice, asthma is defined by the presence of both the following: (1) excessive variation in 
lung function (‘variable airflow limitation’, i.e. variation in expiratory airflow that is greater 
than that seen in healthy people); and (2) respiratory symptoms (e.g. wheeze, shortness of 
breath, cough, chest tightness) that vary over time and may be present or absent at any point 
in time (National Asthma Council Australia 2014).  
Bronchitis: Inflammation of the main air passages (the bronchi). May be acute (because of 
infection) or chronic (most often because of tobacco smoking). 
Cancer: A large range of diseases, in which some of the body’s cells become defective, begin 
to multiply out of control, can invade and damage the area around them, and can also 
spread to other parts of the body to cause further damage. 
Cardiovascular disease: Any disease of the circulatory system, namely the heart (cardio) or 
blood vessels (vascular). Includes heart attack, angina, stroke and peripheral vascular 
disease. Also known as circulatory disease. 
Case-fatality rate: The proportion of reported cases of a specified disease or condition (such 
as asthma or COPD) which are fatal within a specified time period. 
Cause of death: See Underlying cause of death and Associated cause of death. 
Cerebrovascular disease: Any disorder of the blood vessels supplying the brain or its 
covering membranes. A notable and major form of cerebrovascular disease is stroke. 
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Chronic bronchitis: A condition with the presence of cough and sputum production for at 
least 3 months in each of two consecutive years (GOLD 2014). 
Chronic obstructive pulmonary disease (COPD): A preventable and treatable disease with 
some significant extra-pulmonary effects that may contribute to the severity in individual 
patients. Its pulmonary component is characterized by airflow limitation that is not fully 
reversible. The airflow limitation is usually progressive and associated with an abnormal 
inflammatory response of the lung to noxious particles or gases (GOLD 2014). It may be 
characterised by Emphysema and/or Chronic bronchitis. By far the greatest cause is cigarette 
smoking. 
Confidence interval (CI): A statistical term describing a range (interval) of values within 
which we can be ‘confident’ that the true value lies. For this report, confidence intervals are 
calculated using the 95% confidence level. A 95% confidence interval implies that there is 
95% confidence that the true value will be included in this interval. 
Country of birth: This term is used to describe the multicultural nature of the Australian 
population, including those from English-speaking countries and those from countries where 
English is not spoken as the first language. See also English-speaking country of birth and Non-
English-speaking country of birth. 
Diabetes mellitus: A chronic condition in which the body cannot properly use its main 
energy source, the sugar glucose. This is due to a relative or absolute deficiency in insulin, a 
hormone produced by the pancreas. Insulin helps glucose enter the body’s cells from the 
bloodstream and then be processed by them. Diabetes is marked by an abnormal build-up of 
glucose in the blood and it can have serious short- and long-term effects. The three main 
types of diabetes are type I diabetes, type II diabetes and gestational diabetes. 
Emphysema: A chronic lung disease where over-expansion or destruction of the lung tissue 
limits oxygen uptake, leading to shortness of breath and other problems. 
English-speaking country of birth: Includes anyone born in Australia, New Zealand, United 
Kingdom, Ireland, United States of America, Canada, Zimbabwe or South Africa (DIMIA 
English proficiency group 1). 
Health risk factor: Any factor that represents a greater risk of a health disorder or other 
unwanted condition or event. Some risk factors are regarded as causes of disease, others are 
not necessarily so.  
Indigenous: A person of Aboriginal and/or Torres Strait Islander descent who identifies as 
an Aboriginal and/or Torres Strait Islander. See also Aboriginal or Torres Strait Islander. 
International Classification of Diseases (ICD): 
International Statistical Classification of Diseases and Related Health Problems. The World 
Health Organization’s internationally accepted statistical classification of death and disease. 
The 10th Revision (ICD-10) is used for deaths data from 1997 onward.  
Life expectancy: An indication of how long a person can expect to live. Technically it is the 
expected number of years of life remaining to a person at a particular age if mortality rates 
do not change. 
Mortality: Death. 
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Non-English-speaking country of birth: This term is used to describe people who have 
settled in Australia but who come from countries where English is not the primary language 
spoken. Includes people born in all countries not identified as English-speaking-background 
countries (equivalent to DIMIA English proficiency groups 2 to 4). See also English-speaking 
country of birth. 
Non-Indigenous: People who have declared they are not of Aboriginal or Torres Strait 
Islander descent.  
Other Australians: People who have declared they are not of Aboriginal or Torres Strait 
Islander descent, or whose status is not known.  
Prevalence: The number or proportion (of cases, instances, and so forth) present in a 
population at a given time. 
Quintile: A group derived by ranking the population according to specified criteria and 
dividing it into five equal parts. 
Rate: A rate is one number (the numerator) divided by another number (the denominator). 
The numerator is commonly the number of events in a specified time period. The 
denominator is the population ‘at risk’ of the event. Rates (crude, age-specific and age-
standardised) are generally multiplied by a number such as 100,000 to create whole 
numbers. In this report, all the mortality rates presented are age-standardised (see age-
standardisation). 
Risk factor: See Health risk factor. 
SEIFA Index of Relative Socioeconomic Disadvantage: An index of socioeconomic status 
which provides a summary score for a range of key socioeconomic variables that are related 
to health status, including household income and resources, education, occupation, fluency 
in English, and Indigenous status. 
Underlying cause of death: the condition, disease or injury that initiated the train of events 
leading directly to death, or the circumstances of the accident or violence that produced the 
fatal injury. Deaths are referred to in this report as ‘due to’ the underlying cause of death. (See 
Box 1.2 for more information.) 
Wheeze: Breathing difficulty accompanied by an audible whistling sound. 
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Mortality from asthma and COPD 
in Australia 
Asthma death rates in Australia are high compared 
with many other countries and chronic obstructive 
pulmonary disease (COPD) is a leading cause of deaths in 
Australia and internationally. This report provides current 
information about mortality due to these conditions in 
Australia, examining trends over time, seasonal variation, 
international comparison and variation by age, sex, 
remoteness, Indigenous status, country of birth and 
socioeconomic disadvantage.
